Last updated: March 7, 2026
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Overall Status: Active - Recruiting
Phase
N/A
Condition
Neurologic Disorders
Neuropathy
Dystonias
Treatment
N/AClinical Study ID
NCT05041387
10000560
000560-N
Ages 18-110 All Genders
Study Summary
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
The patient or the patient's Legally Authorized Representative is capable ofinformed consent and signs the consent form.
Male or female, age 18 and over, no age limit
Possible neuromuscular disorder or neurodegenerative disorder.
Exclusion
EXCLUSION CRITERIA:
No other exclusion criteria for patients
Study Design
Total Participants: 200
Study Start date:
June 24, 2024
Estimated Completion Date:
May 01, 2031
Study Description
Connect with a study center
National Institutes of Health Clinical Center
Bethesda, Maryland 20892
United StatesActive - Recruiting
National Institutes of Health Clinical Center
Bethesda 4348599, Maryland 4361885 20892
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.